Evidence mapPaperPMID 37626613Full record

ArticleBiomedicines2023

Obesity in Severe COVID-19 Patients Has a Distinct Innate Immune Phenotype.

Ayane de Sá Resende, Yrna Lorena Matos de Oliveira, Mariana Nobre Farias de Franca, Lucas Sousa Magalhães, Cristiane Bani Correa, Kiyoshi Ferreira Fukutani, Michael Wheeler Lipscomb, Tatiana Rodrigues de Moura

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ayane de Sá ResendeHealth Sciences Graduate Program, Federal University of Sergipe, Aracaju 49060-100, Sergipe, Brazil.ORCID 0000-0002-6133-7091
Yrna Lorena Matos de OliveiraHealth Sciences Graduate Program, Federal University of Sergipe, Aracaju 49060-100, Sergipe, Brazil.
Mariana Nobre Farias de FrancaHealth Sciences Graduate Program, Federal University of Sergipe, Aracaju 49060-100, Sergipe, Brazil.
Lucas Sousa MagalhãesHealth Sciences Graduate Program, Federal University of Sergipe, Aracaju 49060-100, Sergipe, Brazil.ORCID 0000-0002-2169-7463
Cristiane Bani CorreaHealth Sciences Graduate Program, Federal University of Sergipe, Aracaju 49060-100, Sergipe, Brazil.
Kiyoshi Ferreira FukutaniHealth Sciences Graduate Program, Federal University of Sergipe, Aracaju 49060-100, Sergipe, Brazil.
Michael Wheeler LipscombDepartment of Pharmacology, University of Minnesota, Minneapolis, MN 55455, USA.
Tatiana Rodrigues de MouraHealth Sciences Graduate Program, Federal University of Sergipe, Aracaju 49060-100, Sergipe, Brazil.
Universidade Federal de Sergipe · BRUniversity of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity alters the capacity of effective immune responses in infections. To further address this phenomenon in the context of COVID-19, this study investigated how the immunophenotype of leukocytes was altered in individuals with obesity in severe COVID-19. This cross-sectional study enrolled 27 ICU COVID-19 patients (67% women, 56.33 ± 19.55 years) that were assigned to obese (BMI ≥ 30 kg/m

Indexed as

body mass indexCOVID-19innate immune responsesobesitySARS-CoV-2

Identifiers

PMID37626613
PMCPMC10452870
OpenAlexW4385363912

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.